This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women
TRIALS AND TRUST: This is the first part of a series on health equity and diversity in clinical trials and cancer research.
In her living room, Laura Esserman, a breast cancer surgeon at the University of California, San Francisco, was singing. The first time Esserman sang in the OR, she watched an anxious patient’s blood pressure gently calm down on the vitals monitor. Now Esserman, a lifelong musical theater performer, serenades them with the song of their choice as the anesthesiologist guides them into blackness.
